Concord, a music rights investor, has agreed to buy Hipgnosis Songs Fund Ltd. in a deal that values the song catalog company at about $1.4 billion.
The bidders have offered Hipgnosis investors $1.16 per share in cash, representing a premium of 32% from the last closing price, the companies said in a statement on Thursday. Hipgnosis’ board has unanimously agreed to the deal, and said in the statement that it’s unlikely that the share price will increase to reflect the company’s performance because of “numerous company-specific and certain market issues.”
Shares in Hipgnosis rose 31% at 8.06 a.m. in London on Thursday.
The deal caps a period of turmoil for the troubled fund. Founded in 2018 in London by Merck Mercuriadis, a former manager of Elton John and Beyonce, Hipgnosis bought up song catalogs for artists including the Red Hot Chili Peppers, Journey and Neil Young at a cost of more than $2 billion with the goal of turning music into an asset class.
But the fund struggled to recoup its investment in music rights. The company launched a strategic review last year and hired music rights specialist Shot Tower, resulting in a cut to its song portfolio valuation of more than a quarter. In March, Hipgnosis again cut the value of its portfolio after uncovering an accounting error. The company’s shares have declined 2.1% this year and closed at 70.5 pence in London trading on Wednesday.
Nashville-based Concord, whose legal name is Alchemy Copyrights, buys up music rights and companies. Its catalog spans theater, recorded music and publishing and includes artists such as Creedence Clearwater Revival and Iggy Pop. Apollo Global Management will provide financing in the form of debt capital, as well as a minority, indirect equity interest in the acquiring entity.
Copyright Bloomberg News
Chicago-based Mesirow Fiduciary Solutions adds flexPATH's plan-level outsourced fiduciary book, boosting its retirement market reach to $164 billion.
Also, Raymond James's employee advisor channel adds breakaways from Wells Fargo and Stifel, while UBS welcomes an ex-Morgan Stanley duo in Indiana.
It promised guaranteed principal and 10% monthly returns. The SEC says it invested nothing.
Ten years after entering the fee-based annuity market, MassMutual Ascend says nearly half its lifetime sales came in the past two years alone – but barriers remain among fee-only advisors.
Amplify, WealthReach, Zeplyn and Zocks have unveiled partnerships aimed at automating portfolio management, content creation, account opening, and client communication.
Northern Trust’s Ken Lassner shows advisors how to convert volatility into after-tax portfolio gains
Dan Biagini of American Equity says the steady decline of pensions, longer lifespans and a reset in interest rates are rewriting how advisors build retirement income
